CellSource Co., Ltd. Stock Price

TSE:4880 Community·JP¥10.0b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

4880 Share Price Performance

JP¥0

-1107.00 (-100.00%)

JP¥0

-1107.00 (-100.00%)

JP¥0

Mon, 17 Nov 25

Share Pricen/a

4880 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks

1 Reward

View Full Analysis

CellSource Co., Ltd. Key Details

Last Reported Earnings

Jul 31, 2024

Next Reporting Earnings

Dec 11, 2025

: 31.39
: 64.64%
: 14.00%
: 0%

View Full Analysis

About 4880

Founded: 2015
Employees: n/a
CEO: Masayuki Yamakawa
WebsiteView website: www.cellsource.co.jp

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients’ adipose tissues, and to prepare platelet-rich plasma from patients’ blood; and offers support services for medical facilities providing regenerative medicine therapy, as well as manufacturing processed cells. It is also involved in the development and sale of Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.